Supplementary Figure Legends
Supplementary Figure S1 . Differences in individual human milk oligosaccharides (HMOs) between infants who were sick and those who were not sick. Plots are divided by sick (■) vs. not sick (■) infants, displaying average and standard error bars for relative abundances of (A) F-LNO (fucosyllacto-N-octaose) at week 4, (B) MFpLNH IV (fucosyl-para-lacto-N-hexaose) at week 16, and (C) IFLNH III (isomer III fucosyl-paralacto-N-hexaose) at week 16. P-value based on Mann-Whitney U tests. HMO structures pictured with monosaccharides Glc (•), Gal (•), GlcNAc (■), and Fuc (▲).
Supplementary Figure S2.
Relative abundance plots showing the differences in the gut microbiota between infants who were sick and those who were not. The plots show the classwise distribution of the enriched taxa at the lowest taxonomic level at which they are enriched. Figure S3 . Box plots displaying change in infant fecal calprotectin levels (mg/kg) at 4, 16, and 20 weeks postpartum. Median is given as a line, 25th and 75th percentiles are the top and bottom of the box, whiskers are data within 1.5*(75th -25th percentile) of the median, outliers displayed as dots above the box. N at each week given above plot with P-value based on linear mixed effects model. Figure S4 . Relative abundance plots showing the differences in the gut microbiota between infants categorized into having normal, borderline, or abnormal calprotectin levels. The plots show the class-wise distribution of the enriched taxa at the lowest taxonomic level at which they are enriched. Figure S5 . Cladogram plots of microbiota enriched in infants categorized by (A) WAZ and (B) HAZ scores. Infants with WAZ scores <-2 were assigned as "underweight," infants with scores >-2 were "desired weight," infants with HAZ scores <-2 were assigned as "stunted," and infants with scores >-2 were "not stunted." Plots indicate microbes that were enriched in infants who were at desired weight (■) or underweight (■), and not stunted (■) or stunted (■) based on LefSe analysis. Supplementary Figure S3 . Infant fecal calprotectin levels by week.
Supplementary

Supplementary Figure S5 . Cladograms of microbiota enriched in infants separated by growth outcomes.
